Clinical Trials Directory

Trials / Unknown

UnknownNCT04470232

Transcultural and Psychometric Validation of SUSHI and HOOS-12 Scores in Patients With Coxofemoral Pathologies

Status
Unknown
Phase
Study type
Observational
Enrollment
120 (estimated)
Sponsor
University Hospital Center of Martinique · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The management of coxofemoral pathologies is constantly increasing. In addition to degenerative hip pathology, the orthopedic surgeon is now confronted with pathologies such as femoro-acetabular conflict, pathologies of the gluteus medius and pathologies of the labrum whose early management limits arthritis degeneration. These pathologies are mainly encountered in young subjects (\<60 years). Self-questionnaires play an important role in understanding patients' point of view on the impact of their coxofemoral pathologies and also allow an assessment of their condition after treatment. For the evaluation of coxofemoral pathologies in the young subject (\<60 years) the Super Simple Hip score (SUSHI-score) was developed and validated. In the elderly subject with hip osteoarthritis, the HOOS score has the advantage of specifically measuring pain, symptoms, function and quality of life, but is made up of 40 items and is often considered rather heavy to submit. However, it has recently been simplified and the HOOS-12 (HOOS score with 12 items) has been developed and validated. These two scores are useful in current clinical practice but they are only validated in English.

Conditions

Interventions

TypeNameDescription
OTHERSelf-assessment questionnaires120 patients with coxofemoral pathologies will pass the SUSHI-score and the HOOS-12 score questionnaires. The HAGOS (Hip and Groin Score) questionnaire will be also passed by the subject, for the convergent validity.

Timeline

Start date
2020-09-11
Primary completion
2022-09-01
Completion
2023-03-01
First posted
2020-07-14
Last updated
2022-06-13

Locations

3 sites across 2 countries: France, Martinique

Source: ClinicalTrials.gov record NCT04470232. Inclusion in this directory is not an endorsement.